GET THE APP

Internal Medicine: Open Access

Internal Medicine: Open Access
Open Access

ISSN: 2165-8048

+44 1300 500008

Internal Medicine: Open Access : Citations & Metrics Report

Articles published in Internal Medicine: Open Access have been cited by esteemed scholars and scientists all around the world. Internal Medicine: Open Access has got h-index 9, which means every article in Internal Medicine: Open Access has got 9 average citations.

Following are the list of articles that have cited the articles published in Internal Medicine: Open Access.

  2021 2020 2019 2018 2017 2016

Year wise published articles

63 21 16 36 34 22

Year wise citations received

62 56 42 57 50 44
Journal total citations count 404
Journal impact factor 0.83
Journal 5 years impact factor 1.74
Journal cite score 1.67
Journal h-index 9
Journal h-index since 2018 8
Important citations (176)

Omentin-1, visfatin, and adiponectin levels in relation to bone mineral density in iranian postmenopausal women

Weil, hongxu l,jie w. analysis of syndrome elements and application combination of 2434 cases of hypertensive renal damage. chinese j trad chinese med 2016; 31 (1): 107-111.

Lim dw, kim h, kim ym, chin yw, park wh, kim je et al. drug repurposing in alternative medicine: herbal digestive sochehwan exerts multifaceted effects against metabolic syndrome sci rep 2019;9(1):9055.

Ashfaq t, feng b. herbal medicines for cardiovascular diseases. evid based complement alternat med2014;2014

Xiong x, feng b, yang x, liu w, wang j. chinese herbal medicine for the treatment of prehypertension. evid based complement alternat med 2013; 2013: 493521

Yang xx, feng b. moxibustion for essential hypertension. methods 2013;8:9.

Chu f, sun q, xing w, zhang z, zhang d, chen j, et al. shen-yuan-dan, a chinese herbal formula derived from buyang huanwu decoction, improves short-term quality of life in unstable angina patients undergoing early percutaneous coronary intervention: a pilot randomized controlled trial.

Weil,jiang xx, jie w. exploring chinese traditional medicine for hypertension. j shanghai univ trad chinese med 2013; 27 (4): 86-91.

Jiang xx, xiaochen y, weil,bo f,lian d. classical prescriptions and aids treatment. china j chinese mater med 2013; 38(15):2510-2512.

Guozhong z, wenjun h, junlan l. efficacy of wenxin granules combined with metoprolol in the treatment of ventricular premature beats of right ventricular outflow tract. modern dist edu chinese med 2015;11:61-62.

Weil, jie w. application of diarrhea in fever of aids. china j chinese mater med. 2013;38(15):2513-2515.

Weil, jiang xx, wang jie. the theory of escape from diseases. chinese j trad chinese med 2013;28(10):2847-2850.

Weil, wang jie,jiang xx. progress in diagnosis and treatment of salt-sensitive hypertension and thoughts on prevention and treatment of traditional chinese medicine. chinese j trad chinese med. 2013;28(9):2661-2665.

Xiaochen y,jiang xx,yun z, yongmei l, jie w. effects of bushen jiangya recipe on adiponectin and insulin resistance in spontaneously hypertensive rats. world jinte trad chinese western med 2013 ;8(11):1107-1110.

Effect of bushen jiangya recipe on adiponectin and insulin resistance in spontaneously hypertensive rats

Jiang xx, yang x, jie w, liu y, wamg p. clinical practice of classic mingfang in treating hypertension. china j chinese mater medi 2014; 39(5):929-933.

Tian pp, li j, gao j, li y. efficacy and safety of the shexiang baoxin pill for the treatment of coronary artery disease not amenable to revascularisation: study protocol for a randomised, placebo-controlled, double-blinded trial. bmj open 2018;8(2):018052.

Wang j, xiong x, liu w. chinese patent medicine tongxinluo capsule for hypertension: a systematic review of randomised controlled trials. evid based complement alternat med 2014;2014.

Liu wei, xiong xingjiang, wang jie. hypertensive renal damage and progress in prevention and treatment of traditional chinese medicine. china j chinese mater med 2014;39(1):14-29.

Xiong x, yang x, duan l, liu w, zhang y, liu y, et al. traditional chinese medicine suppresses left ventricular hypertrophy by targeting extracellular signal-regulated kinases signaling pathway in spontaneously hypertensive rats. sci rep 2017; 7:42965.

Top